Popularity of Traditional Chinese Medicine Use Among Breast Cancer Patients in North China: A Cross-Sectional Study
Rong Zhao,Jianyong Zhang,Qingxiang Gou,Jinnan Gao
DOI: https://doi.org/10.2147/BCTT.S416998
2023-08-11
Breast Cancer: Targets and Therapy
Abstract:Rong Zhao, 1, &ast Jianyong Zhang, 2, &ast Qingxiang Gou, 3 Jinnan Gao 1, 2 1 General Surgery Department, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, People's Republic of China; 2 Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, People's Republic of China; 3 School of Public Health, Shanxi Medical University, Taiyuan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jinnan Gao, General Surgery Department, Shanxi Bethune Hospital, Longcheng Street 99, Taiyuan, Shanxi, 030032, People's Republic of China, Tel +86 15135086600, Email Background: The role of traditional Chinese medicine (TCM) in breast cancer treatment is controversial. The aim of this study is to explore the popularity of TCM among the breast cancer patients who have been treated with Western medicine (WM) in north China. Methods: An observational, cross-sectional study was conducted. We consecutively recruited 691 breast cancer patients who were diagnosed in Shanxi Bethune Hospital between 1 January 2017 and 31 December 2020 and completed follow-up between June and August 2022. A self-designed questionnaire was used for data collection. Participants were asked about TCM use by phone. Univariate and multivariate analyses were performed as appropriate. Results: At median follow-up of 41 months (range, 17– 61 months), 326 (47.2%) participants used TCM. The results of multivariate logistic regression showed that residential area, education, annual income per capita, experienced TCM treatment before, stage of diagnosis, and trust in TCM were independent predictors of TCM use. The detail of TCM use and the reason for non-TCM use were presented comprehensively. Conclusion: The use of TCM was prevalent among breast cancer patients treated with WM in north China. If WM physician encourage the patients with higher intention to use TCM and provide them with appropriate advices, the quality of life of patients will be further improved through integrating TCM into standard adjuvant therapy. Keywords: traditional Chinese medicine, breast cancer, cross-sectional study, China Traditional Chinese medicine dates back thousands of years. It is based on the yin–yang theory and the five elements theory, with a holistic, traditional system, and has developed from practical life of the Chinese nation. 1 TCM has its special cultural style and enriched experience. 2 With thousands of years of development, TCM is recognized for various diagnostic and treatment advantages for various diseases. Until the end of the nineteenth century, TCM was the only healthcare security choice for the Chinese. 1 Interestingly, most Chinese doctors have only undergraduate training in Western medicine. 3 This has led to Western medicine currently dominating the treatment of carcinoma in China, especially in general hospitals based on Western medicine. Breast cancer has become the most prevalent malignant tumor globally, including in China, with the highest incidence rate. 4 Progress has been achieved in treating breast cancer in the Western medicine system, with significant effects and good prognoses. 5,6 Research on the occurrence and development of breast cancer has been performed at the genetic and signaling levels. The major means of breast cancer treatment include surgery, radiation, chemotherapy, targeted therapies, endocrine treatment, and immunotherapy. 7 From the TCM point of view, Qi stagnation and blood stasis are the two main causes of breast cancer. Blood stasis syndrome affects most tumor patients to varying degrees. A person with breast cancer has poor emotions and stagnating liver Qi, resulting in poor blood circulation and an illness affecting the collaterals, thereby leading to blood stasis symptoms. 8 Traditional Chinese medicine (TCM) treatment of breast cancer emphasizes a holistic approach and individualized care. Western medicine, on the other hand, possesses more advanced technology and evidence-based support in the treatment of breast cancer. In recent years, scholars have conducted research on the pathophysiological mechanisms of TCM in cancer treatment and have made some progress. 9 Although traditional Chinese medicine and Western medicine hold different therapeutic concepts, each has its own characteristic advantages. According to a national survey conducted in China, there were 1,030,935 health institutions in 2021, of which 77,336 were TCM- -Abstract Truncated-